Dr. Donald Kohan, MD

NPI: 1235229840
Total Payments
$154,658
2024 Payments
$38,975
Companies
7
Transactions
121

Payment Breakdown by Category

Consulting$112,529 (72.8%)
Travel$22,364 (14.5%)
Research$9,021 (5.8%)
Other$7,749 (5.0%)
Food & Beverage$2,994 (1.9%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $112,529 40 72.8%
Travel and Lodging $22,364 35 14.5%
Unspecified $9,021 4 5.8%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $7,749 4 5.0%
Food and Beverage $2,994 38 1.9%

Payments by Type

General
$145,637
117 transactions
Research
$9,021
4 transactions

Top Paying Companies

Company Total Records Latest Year
Travere Therapeutics, Inc. $67,898 64 $0 (2024)
Novartis Pharmaceuticals Corporation $28,923 19 $0 (2024)
Janssen Research & Development, LLC $28,492 11 $0 (2022)
AbbVie, Inc. $26,411 21 $0 (2017)
Retrophin, Inc. $1,426 3 $0 (2018)
AstraZeneca AB $1,400 2 $0 (2021)
Janssen Scientific Affairs, LLC $108.32 1 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2024 $38,975 28 Novartis Pharmaceuticals Corporation ($28,799)
2023 $34,162 40 Travere Therapeutics, Inc. ($34,037)
2022 $13,375 3 Janssen Research & Development, LLC ($13,250)
2021 $9,150 5 Travere Therapeutics, Inc. ($7,750)
2020 $22,248 12 Travere Therapeutics, Inc. ($15,810)
2019 $625.00 1 Janssen Research & Development, LLC ($625.00)
2018 $9,431 10 Janssen Research & Development, LLC ($7,896)
2017 $26,693 22 AbbVie, Inc. ($26,411)

All Payment Transactions

121 individual payment records from CMS Open Payments — Page 1 of 5

Date Company Product Nature Form Amount Type
10/15/2024 Travere Therapeutics, Inc. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,583.00 General
10/15/2024 Travere Therapeutics, Inc. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,583.00 General
10/14/2024 Travere Therapeutics, Inc. Travel and Lodging In-kind items and services $118.39 General
09/20/2024 Travere Therapeutics, Inc. Travel and Lodging In-kind items and services $676.96 General
09/20/2024 Travere Therapeutics, Inc. Travel and Lodging In-kind items and services $476.52 General
09/20/2024 Travere Therapeutics, Inc. Food and Beverage In-kind items and services $405.16 General
09/06/2024 Novartis Pharmaceuticals Corporation Consulting Fee Cash or cash equivalent $7,850.00 General
09/06/2024 Novartis Pharmaceuticals Corporation Travel and Lodging In-kind items and services $781.63 General
09/06/2024 Novartis Pharmaceuticals Corporation Travel and Lodging In-kind items and services $295.26 General
09/06/2024 Novartis Pharmaceuticals Corporation Food and Beverage In-kind items and services $175.44 General
09/06/2024 Novartis Pharmaceuticals Corporation Travel and Lodging In-kind items and services $80.00 General
09/06/2024 Novartis Pharmaceuticals Corporation Food and Beverage In-kind items and services $20.96 General
09/05/2024 Novartis Pharmaceuticals Corporation Food and Beverage In-kind items and services $139.13 General
07/31/2024 Novartis Pharmaceuticals Corporation Consulting Fee Cash or cash equivalent $3,725.00 General
06/18/2024 Travere Therapeutics, Inc. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,291.50 General
06/18/2024 Travere Therapeutics, Inc. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,291.50 General
06/18/2024 Travere Therapeutics, Inc. Consulting Fee Cash or cash equivalent $375.00 General
06/18/2024 Travere Therapeutics, Inc. Consulting Fee Cash or cash equivalent $375.00 General
06/07/2024 Novartis Pharmaceuticals Corporation Consulting Fee Cash or cash equivalent $3,900.00 General
06/06/2024 Novartis Pharmaceuticals Corporation Consulting Fee Cash or cash equivalent $2,600.00 General
02/09/2024 Novartis Pharmaceuticals Corporation Consulting Fee Cash or cash equivalent $7,200.00 General
02/09/2024 Novartis Pharmaceuticals Corporation Travel and Lodging In-kind items and services $431.52 General
02/09/2024 Novartis Pharmaceuticals Corporation Travel and Lodging Cash or cash equivalent $368.88 General
02/09/2024 Novartis Pharmaceuticals Corporation Food and Beverage In-kind items and services $209.97 General
02/09/2024 Novartis Pharmaceuticals Corporation Travel and Lodging In-kind items and services $88.26 General

Research Studies & Clinical Trials

Study Name Company Amount Records
M11-352 AbbVie, Inc. $4,521 3

About Dr. Donald Kohan, MD

Dr. Donald Kohan, MD is a Nephrology healthcare provider based in Salt Lake City, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1235229840.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Donald Kohan, MD has received a total of $154,658 in payments from pharmaceutical and medical device companies, with $38,975 received in 2024. These payments were reported across 121 transactions from 7 companies. The most common payment nature is "Consulting Fee" ($112,529).

Practice Information

  • Specialty Nephrology
  • Location Salt Lake City, UT
  • Active Since 10/13/2006
  • Last Updated 07/08/2007
  • Taxonomy Code 207RN0300X
  • Entity Type Individual
  • NPI Number 1235229840

Products in Payments

  • INVOKANA (Drug) $8,912

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Nephrology Doctors in Salt Lake City